NCT03744364

Brief Summary

Purpose: To compare the efficacy and safety of low-dose protocol of vaginal misoprostol and vaginal dinoprostone insert for induction of labor in women with post-term pregnancies. Methods: The investigators designed a prospective, randomized, open-labeled, blinded for the end-point evaluators trial including women of at least 41 weeks of gestational age with uncomplicated singleton pregnancies and Bishop score lower than 6. Participants were randomized into dinoprostone or misoprostol groups in a 1:1 ratio. Baseline maternal data and perinatal outcomes were recorded for statistical analysis. Successful vaginal delivery within 24 hours was the primary outcome variable.

Trial Health

100
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
198

participants targeted

Target at P50-P75 for phase_4

Timeline
Completed

Started Jun 2014

Longer than P75 for phase_4

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

June 1, 2014

Completed
3.4 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 20, 2017

Completed
12 days until next milestone

Study Completion

Last participant's last visit for all outcomes

November 1, 2017

Completed
1 year until next milestone

First Submitted

Initial submission to the registry

November 9, 2018

Completed
7 days until next milestone

First Posted

Study publicly available on registry

November 16, 2018

Completed
Last Updated

November 16, 2018

Status Verified

November 1, 2018

Enrollment Period

3.4 years

First QC Date

November 9, 2018

Last Update Submit

November 15, 2018

Conditions

Keywords

DinoprostoneMisoprostol

Outcome Measures

Primary Outcomes (1)

  • Successful vaginal delivery within 24 hours

    Percentage of women that achieve a vaginal delivery within 24 hours since induction process started

    24 hours since induction was started

Secondary Outcomes (4)

  • Successful cervical ripening within 24 hours

    24 hours since induction was started

  • Interval time from induction to delivery

    Hours passed between induction of labor until delivery within 72 hours

  • Need for a second induction

    Assessed 24 hours since induction of labor was started

  • Vaginal delivery rate

    Since labor induction had started until delivery had ocurred within 72 hours

Study Arms (2)

Misoprostol

ACTIVE COMPARATOR

Group of women allocated to misoprostol induction.

Drug: Misoprostol 25 mcg

Dinoprostone

ACTIVE COMPARATOR

Group of women allocated to dinoprostone induction.

Drug: Dinoprostone 10mg

Interventions

To determine efficacy and safety of vaginal 'Misoprostol 25 mcg' every 4 hours with a maximum of 6 doses for induction of labor.

Also known as: Misoprostol induction
Misoprostol

To determine efficacy and safety of 'Dinoprostone 10mg' vaginal insert for induction of labor.

Also known as: Dinoprostone induction
Dinoprostone

Eligibility Criteria

Age18 Years - 50 Years
Sexfemale(Gender-based eligibility)
Gender Eligibility DetailsPregnant women
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • Singleton uncomplicated pregnancy
  • Nulliparity
  • Live fetus
  • days of gestational age or above
  • Abscence of contraindication for vaginal delivery
  • Bishop score lower than 6

You may not qualify if:

  • Multiple pregnancy
  • Multiparity
  • Stillbirth
  • Oligohydramnios
  • Suspected fetal distress
  • Severe asthma
  • Intolerance/allergy to prostaglandins
  • Contraindication for vaginal birth

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Related Publications (1)

  • De Bonrostro Torralba C, Tejero Cabrejas EL, Envid Lazaro BM, Franco Royo MJ, Roca Arquillue M, Campillos Maza JM. Low-dose vaginal misoprostol vs vaginal dinoprostone insert for induction of labor beyond 41st week: A randomized trial. Acta Obstet Gynecol Scand. 2019 Jul;98(7):913-919. doi: 10.1111/aogs.13556. Epub 2019 Feb 24.

MeSH Terms

Interventions

MisoprostolDinoprostone

Intervention Hierarchy (Ancestors)

Prostaglandins E, SyntheticProstaglandins, SyntheticProstaglandinsEicosanoidsFatty Acids, UnsaturatedFatty AcidsLipidsAutacoidsInflammation MediatorsBiological FactorsProstaglandins E

Study Design

Study Type
interventional
Phase
phase 4
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Head of Unit of Maternal-Fetal Medicine

Study Record Dates

First Submitted

November 9, 2018

First Posted

November 16, 2018

Study Start

June 1, 2014

Primary Completion

October 20, 2017

Study Completion

November 1, 2017

Last Updated

November 16, 2018

Record last verified: 2018-11

Data Sharing

IPD Sharing
Will not share